New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
04:55 EDTACHC, ACHC, ACHC, BABY, BABY, BABY, CNC, CNC, CNC, INCY, INCY, INCY, AUXL, AUXL, AUXL, HGR, HGR, HGR, ALKS, ALKS, ALKS, ACHN, ACHN, ACHN, MZOR, MZOR, MZOR, LMNX, LMNX, LMNX, IDIX, IDIX, IDIXUBS to hold a conference
Global Healthcare Conference to be held in New York on May 19-21.
News For IDIX;LMNX;MZOR;ACHN;ALKS;HGR;AUXL;INCY;CNC;BABY;ACHC From The Last 14 Days
Check below for free stories on IDIX;LMNX;MZOR;ACHN;ALKS;HGR;AUXL;INCY;CNC;BABY;ACHC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 17, 2014
06:36 EDTAUXLEndo volatility expected to move on Endo acquisition proposal
Subscribe for More Information
06:25 EDTAUXLAuxilium volatility expected to move on Endo acquisition proposal
Subscribe for More Information
September 16, 2014
17:29 EDTAUXLAuxilium up 42% following Endo acquisition proposal
16:48 EDTAUXLEndo delivers proposal to acquire Auxilium for $28.10 per share in cash, stock
Subscribe for More Information
16:48 EDTAUXLEndo delivers proposal to acquire Auxilium for $2.2B in cash, stock
Subscribe for More Information
September 15, 2014
10:11 EDTMZORFDA posts 510(k) clearance for Mazor Robotics stereotaxic instrument
Subscribe for More Information
07:55 EDTALKSAlkermes shares attractive ahead of Q1 catalysts, says Leerink
Leerink says its recent meeting with Alkermes management confirmed its conviction that the company is executing on its growth strategy. Leerink believes clinical trials for ALKS 8700 in multiple sclerosis, ALKS 7106 in abuse deterrent opiate analgesic and the Phase II trial for ALKS 3831 in schizophrenia are all billion dollar market opportunities that are not reflected in the current stock price. The firm finds the stock attractively valued ahead of clinical data readouts that start in early Q1 of 2015. It reiterates an Outperform rating on Alkermes with a $66 price target.
September 14, 2014
13:51 EDTAUXLAuxilium looks like 'overpriced tax shelter', Barron's says
Auxilium's (AUXL) acquisition of QLT (QLTI) for tax inversion purposes followed a collapse in Testim sales and the company "seems like an overpriced tax shelter," Barron's argues in a follow up article. Reference Link
September 12, 2014
13:48 EDTINCYArray names Sandor Chief Medical Officer to replace Needle
Subscribe for More Information
11:59 EDTAUXLAuxilium management to meet with Jefferies
Subscribe for More Information
06:00 EDTACHNStocks with implied volatility above IV index mean; DISH ACHN
Stocks with implied volatility top IV index mean; DISH (DISH) 31, Achillion (ACHN) 128 according to iVolatility.
September 11, 2014
16:13 EDTHGRHanger reports Kiraly to join as CFO, succeed McHenry
Hanger announced that Thomas Kiraly, former EVP, CFO, and Treasurer of Sheridan Healthcare, will join Hanger as EVP on Oct. 1 and will become CFO during Q4. Kiraly will work closely with incumbent CFO George McHenry until Mr. Kiraly assumes the role of CFO later this year. As previously announced, McHenry will retire on Dec. 31.
10:19 EDTCNCCentene management to meet with Oppenheimer
Meeting to be held in St. Louis on September 11 hosted by Oppenheimer.
09:18 EDTINCYIncyte management to meet with Leerink
Subscribe for More Information
September 10, 2014
07:21 EDTAUXLAuxilium sees merger with QLT closing in Q4
Subscribe for More Information
05:58 EDTACHNStocks with implied volatility above IV index mean; DISH ACHN
Subscribe for More Information
September 9, 2014
17:03 EDTAUXLAuxilium announces corporate restructuring, will cut headcount approximately 30%
Subscribe for More Information
16:55 EDTAUXLAuxilium trading halted, pending news
Subscribe for More Information
06:51 EDTALKSAlkermes management to meet with Leerink
Subscribe for More Information
06:03 EDTACHNStocks with implied volatility above IV index mean; DISH ACHN
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use